Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-18

FDA Approved: BONJESTA — Supplemental Application (Duchesnay USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for BONJESTA (doxylamine succinate and pyridoxine hydrochloride) from Duchesnay USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bonjesta (doxylamine succinate and pyridoxine hydrochloride)

Snippet

SUPPL AP for BONJESTA (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)